About the Nanotechnology and Drug Delivery Systems Session
Nanotechnology has introduced transformative possibilities in cancer drug delivery systems. Nanocarriers, such as liposomes and polymer-based nanoparticles, enhance the precision and efficiency of delivering chemotherapeutic agents to tumor sites. These systems improve drug solubility, stability, and bioavailability while minimizing side effects by sparing healthy tissues. Advanced nanotechnology platforms also enable targeted delivery through ligand-receptor interactions, ensuring drugs reach specific cancer cells. Innovations in this field continue to refine treatment outcomes, offering a promising avenue for overcoming traditional chemotherapy limitations.
Topics Covered in Nanotechnology and Drug Delivery Systems
Liposomal Formulations
Polymeric Nanoparticles
Passive Tumor Targeting
Ligand-Targeted Delivery
Stimuli-Responsive Release
Nanotoxicity & Safety
Related Scientific Sessions at CIOC 2027
Why Attend the Nanotechnology and Drug Delivery Systems Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Nanotechnology and Drug Delivery Systems work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Nanotechnology and Drug Delivery Systems research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Nanotechnology and Drug Delivery Systems track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Nanotechnology and Drug Delivery Systems Conference 2027 — FAQs
What is the Nanotechnology and Drug Delivery Systems track at CIOC 2027?
The Nanotechnology and Drug Delivery Systems track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Nanotechnology and Drug Delivery Systems. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Nanotechnology and Drug Delivery Systems sessions?
Cancer researchers and clinicians, educators and students with an interest in Nanotechnology and Drug Delivery Systems are all welcome — whether presenting or attending.
Can I present my research in the Nanotechnology and Drug Delivery Systems track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Nanotechnology and Drug Delivery Systems sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Nanotechnology and Drug Delivery Systems track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.